Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability.
Nguyen TD, Bordeau BM, Balthasar JP. · 2023
Read Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability. by Nguyen TD, Bordeau BM, Balthasar JP. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9913659.txt.
Description
Nguyen and co-authors review why antibody-drug conjugates cause toxicity and how tolerability can improve. These drugs link an antibody to a potent cell-killing agent. Twelve such agents are in clinical use. Many others failed in trials due to excess toxicity.
Even approved drugs often force dose cuts, delays, or stopped treatment. Dose-limiting harms often match the payload, not the target antigen. Much toxicity hits cells that lack the target, an off-target effect. Such harm can cap doses below the best level for tumor control. The authors sort the main toxicity routes. They then discuss design and dosing tactics to widen the safe dose range.
Catalog record
| CREATOR | Nguyen TD, Bordeau BM, Balthasar JP. |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 151 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |